{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T00:56:43Z","timestamp":1792112203779,"version":"4.4.0"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[1996,4,1]],"date-time":"1996-04-01T00:00:00Z","timestamp":828316800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Psychopharmacology"],"published-print":{"date-parts":[[1996,4]]},"DOI":"10.1007\/bf02246662","type":"journal-article","created":{"date-parts":[[2005,11,15]],"date-time":"2005-11-15T14:18:06Z","timestamp":1132064286000},"page":"231-240","source":"Crossref","is-referenced-by-count":68,"title":["Behavioural effects in the rat of the putative dopamine D3 receptor agonist 7-OH-DPAT: comparison with quinpirole and apomorphine"],"prefix":"10.1007","volume":"124","author":[{"given":"R.","family":"Depoortere","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Perrault","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D. J.","family":"Sanger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"BF02246662_CR1","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0014-2999(94)90335-2","volume":"260","author":"S Ahlenius","year":"1994","unstructured":"Ahlenius S, Salmi P (1994) Behavioral and biochemical effects of the dopamine D3 receptor-selective ligand, 7-OH-DPAT, in the normal and the reserpine-treated rat. Eur J Pharmacol 260:177\u2013181","journal-title":"Eur J Pharmacol"},{"key":"BF02246662_CR2","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/0006-8993(94)91052-9","volume":"649","author":"MA Ariano","year":"1994","unstructured":"Ariano MA, Sibley DR (1994) Dopamine receptor distribution in the rat CNS: elucidation using anti-peptide antisera directed against D1A and D3 subtypes. Brain Res 649:95\u2013110","journal-title":"Brain Res"},{"key":"BF02246662_CR3","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/0014-2999(87)90144-0","volume":"133","author":"J Arnt","year":"1987","unstructured":"Arnt J, Hyttel J, Perregaard J (1987) Dopamine D-1 receptor agonists combined with the selective D-2 agonist quinpirole facilitate the expression of oral stereotyped behaviour in rats. Eur J Pharmacol 133:137\u2013145","journal-title":"Eur J Pharmacol"},{"key":"BF02246662_CR4","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/0014-2999(93)91011-B","volume":"239","author":"RJ Baldessarini","year":"1993","unstructured":"Baldessarini RJ, Kula NS, McGrath CR, Bakthavachalam V, Kebabian JW, Neumeyer JL (1993) Isomeric selectivity at dopamine D3 receptors. Eur J Pharmacol 239:269\u2013270","journal-title":"Eur J Pharmacol"},{"key":"BF02246662_CR5","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/0006-8993(94)90827-3","volume":"662","author":"RG Booth","year":"1994","unstructured":"Booth RG, Baldessarini RJ, Marsh E, Owens CE (1994) Actions of (\u00b1)-7-hydroxy-N,N-dipropylaminotetralin (7-OH-DPAT) on dopamine synthesis in limbic and extrapyramidal regions of rat brain. Brain Res 662:283\u2013288","journal-title":"Brain Res"},{"key":"BF02246662_CR6","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/0006-8993(91)91456-B","volume":"564","author":"ML Bouthenet","year":"1991","unstructured":"Bouthenet ML, Souil E, Martres MP, Sokoloff P, Giros B, Schwartz JC (1991) Localization of dopamine D3 receptor mRNA in the rat brain using in situ hybridization histochemistry: comparison with dopamine D2 receptor mRNA. Brain Res 564: 203\u2013219","journal-title":"Brain Res"},{"key":"BF02246662_CR7","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1126\/science.8099761","volume":"260","author":"SB Caine","year":"1993","unstructured":"Caine SB, Koob GF (1993) Modulation of cocaine self-administration in the rat through D-3 dopamine receptors. Science 260:1814\u20131816","journal-title":"Science"},{"key":"BF02246662_CR8","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1097\/00008877-199506000-00004","volume":"6","author":"SB Caine","year":"1995","unstructured":"Caine SB, Koob GF (1995) Pretreatment with the dopamine agonist 7-OH-DPAT shifts the cocaine self-administration dose-effect function to the left under different schedules in the rat. Behav Pharmacol 6:333\u2013347","journal-title":"Behav Pharmacol"},{"key":"BF02246662_CR9","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1111\/j.2042-7158.1977.tb11331.x","volume":"29","author":"B Costall","year":"1977","unstructured":"Costall B, Naylor RJ, Cannon JG, Lee T (1977) Differentiation of the dopamine mechanisms mediating stereotyped behaviour and hyperactivity in the nucleus accumbens and caudate-putamen. J Pharm Pharmacol 29:337\u2013342","journal-title":"J Pharm Pharmacol"},{"key":"BF02246662_CR10","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/0028-3908(93)90177-5","volume":"32","author":"SA Daly","year":"1993","unstructured":"Daly SA, Waddington JL (1993) Behavioural effects of the putative D-3 dopamine receptor agonist 7-OH-DPAT in relation to other \u201cD-2-like\u201d agonists. Neuropharmacology 32:509\u2013510","journal-title":"Neuropharmacology"},{"key":"BF02246662_CR11","doi-asserted-by":"crossref","first-page":"R9","DOI":"10.1016\/0014-2999(93)90533-N","volume":"249","author":"G Damsma","year":"1993","unstructured":"Damsma G, Bottema T, Westerink BHC, Tepper PG, Dijkstra D, Pugsley TA, MacKenzie RG, Heffner TG, Wikstrom H (1993) Pharmacological aspects ofR-(+)-7-OH-DPAT, a putative dopamine D3 receptor ligand. Eur J Pharmacol 249:R9-R10","journal-title":"Eur J Pharmacol"},{"key":"BF02246662_CR12","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/0014-2999(94)00708-F","volume":"274","author":"FR Fonseca De","year":"1995","unstructured":"De Fonseca FR, Rubio P, Martin-Calderon JL, Caine SB, Koob GF, Navarro M (1995) The dopamine receptor agonist 7-OH-DPAT modulates the acquisition and expression of morphine-induced place preference. Eur J Pharmacol 274:47\u201355","journal-title":"Eur J Pharmacol"},{"key":"BF02246662_CR13","first-page":"167","volume-title":"Advances in behavioral pharmacology, vol. 1","author":"PB Dews","year":"1977","unstructured":"Dews PB, Wenger GR (1977) Rate-dependency of the behavioral effects of amphetamine. In: Thompson T, Dews PB (eds) Advances in behavioral pharmacology, vol. 1. Academic, New York, pp 167\u2013227"},{"key":"BF02246662_CR14","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1038\/264564a0","volume":"264","author":"G Chiara Di","year":"1976","unstructured":"Di Chiara G, Porceddu ML, Vargiu L, Argiolas A, Gessa GL (1976) Evidence for dopamine receptors mediating sedation in the mouse brain. Nature 264:564\u2013567","journal-title":"Nature"},{"key":"BF02246662_CR15","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/0014-2999(89)90837-6","volume":"161","author":"D Eilam","year":"1989","unstructured":"Eilam D, Szechtman H (1989) Biphasic effect of D-2 agonist quinpirole on locomotion and movements. Eur J Pharmacol 161: 151\u2013157","journal-title":"Eur J Pharmacol"},{"key":"BF02246662_CR16","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1007\/BF00497015","volume":"324","author":"MGP Feenstra","year":"1983","unstructured":"Feenstra MGP, Sumners C, Goedemoed JH, de Vries JB, Rollema H, Horn AS (1983) A comparison of the potencies of various dopamine receptor agonists in models for pre- and postsynaptic receptor activity. Naunyn-Schmiedeberg's Arch Pharmacol 324:108\u2013115","journal-title":"Naunyn-Schmiedeberg's Arch Pharmacol"},{"key":"BF02246662_CR17","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1111\/j.1749-6632.1988.tb42107.x","volume":"537","author":"HC Fibiger","year":"1988","unstructured":"Fibiger HC, Phillips AG (1988) Mesocorticolimbic dopamine systems and reward. Ann NY Acad Sci 537:206\u2013215","journal-title":"Ann NY Acad Sci"},{"key":"BF02246662_CR18","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/0091-3057(84)90104-7","volume":"20","author":"CR Gallistel","year":"1984","unstructured":"Gallistel CR, Karras D (1984) Pimozide and amphetamine have opposing effects on the reward summation function. Pharmacol Biochem Behav 20:73\u201377","journal-title":"Pharmacol Biochem Behav"},{"issue":"5]","key":"BF02246662_CR19","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1523\/JNEUROSCI.05-05-01246.1985","volume":"5","author":"CR Gallistel","year":"1985","unstructured":"Gallistel CR, Gomita Y, Yadin E, Campbell KA (1985) Fore brain origins and terminations of the medial forebrain bundle metabolically activated by rewarding stimulation or by reward-blocking doses of pimozide. J Neurosci 5 [5]1246\u20131261","journal-title":"J Neurosci"},{"key":"BF02246662_CR20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0006-8993(95)00247-N","volume":"681","author":"DB Gilbert","year":"1995","unstructured":"Gilbert DB, Millar J, Cooper SJ (1995) The putative dopamine D3 agonist, 7-OH-DPAT, reduces dopamine release in the nucleus accumbens and electrical self-stimulation to the ventral tegmentum. Brain Res 681:1\u20137","journal-title":"Brain Res"},{"key":"BF02246662_CR21","doi-asserted-by":"crossref","first-page":"R1","DOI":"10.1016\/0014-2999(94)00738-S","volume":"272","author":"AM Gonzalez","year":"1995","unstructured":"Gonzalez AM, Sibley DR (1995) [3H]7-OH-DPAT is capable of labeling dopamine D2 as well as D3 receptors. Eur J Pharmacol 272:R1-R3","journal-title":"Eur J Pharmacol"},{"key":"BF02246662_CR22","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/0091-3057(76)90200-8","volume":"4","author":"LJ Herberg","year":"1976","unstructured":"Herberg LJ, Stephens DN, Franklin KBJ (1976) Catecholamines and self-stimulation: evidence suggesting a reinforcing role for noradrenaline and a motivating role for dopamine. Pharmacol Biochem Behav 4:575\u2013582","journal-title":"Pharmacol Biochem Behav"},{"key":"BF02246662_CR23","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1016\/0024-3205(88)90036-7","volume":"42","author":"L Hernandez","year":"1988","unstructured":"Hernandez L, Hoebel BG (1988) Food reward and cocaine increase extracellular dopamine in the nucleus accumbens as measured by microdialysis. Life Sci 42:1705\u20131711","journal-title":"Life Sci"},{"key":"BF02246662_CR24","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/0006-8993(94)91121-5","volume":"648","author":"L Herroelen","year":"1994","unstructured":"Herroelen L, De Backer J-P, Wilczak N, Flamez A, Vauquelin G, De Keyser J (1994) Autoradiographic distribution of D3-type dopamine receptors in human brain using [3H]7-hydroxy-N,N-di-n-propyl-2-aminotetralin. Brain Res 648:222\u2013228","journal-title":"Brain Res"},{"key":"BF02246662_CR25","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/0014-2999(94)90317-4","volume":"261","author":"M Hillefors-Berglund","year":"1994","unstructured":"Hillefors-Berglund M, Von Euler G (1994) Pharmacology of dopamine D3 receptors in the islands of Calleja of the rat using quantitative receptor autoradiography. Eur J Pharmacol 261:179\u2013183","journal-title":"Eur J Pharmacol"},{"key":"BF02246662_CR26","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1126\/science.134.3483.943","volume":"134","author":"W Hodos","year":"1961","unstructured":"Hodos W (1961) Progressive ratio as a measure of reward strength. Science 134:943\u2013944","journal-title":"Science"},{"key":"BF02246662_CR27","volume-title":"Advanced data analysis with SYSTAT","author":"KN Kirby","year":"1993","unstructured":"Kirby KN (1993) Advanced data analysis with SYSTAT. Van Nostrand Reinhold, New York"},{"key":"BF02246662_CR28","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1111\/j.1460-9568.1993.tb00480.x","volume":"5","author":"B Landwehrmeyer","year":"1993","unstructured":"Landwehrmeyer B, Mengod G, Palacios JM (1993a) Differential visualization of dopamine D2 and D3 receptor sites in rat brain. A comparative study using in situ hybridization histochemistry and ligand binding autoradiography. Eur J Neurosci 5:145\u2013153","journal-title":"Eur J Neurosci"},{"key":"BF02246662_CR29","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/0169-328X(93)90188-U","volume":"18","author":"B Landwehrmeyer","year":"1993","unstructured":"Landwehrmeyer B, Mengod G, Palacios JM (1993b) Dopamine D3 receptor mRNA and binding sites in human brain. Mol Brain Res 18:187\u2013192","journal-title":"Mol Brain Res"},{"key":"BF02246662_CR30","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/0006-8993(83)90914-9","volume":"277","author":"NJ Leith","year":"1983","unstructured":"Leith NJ (1983) Effects of apomorphine on self-stimulation responding: does the drug mimic the current? Brain Res 277:129\u2013136","journal-title":"Brain Res"},{"key":"BF02246662_CR31","doi-asserted-by":"crossref","first-page":"8155","DOI":"10.1073\/pnas.89.17.8155","volume":"89","author":"D Levesque","year":"1992","unstructured":"Levesque D, Diaz J, Pilon C, Martres MP, Giros B, Souil E, Schott D, Morgat JL, Schwartz JC, Sokoloff P (1992) Identification, characterization, and localization of the dopamine D3 receptor in rat brain using 7-(3H)hydroxy-N, N-di-n-propyl-2- aminotetralin. Proc Natl Acad Sci USA 89:8155\u20138159","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF02246662_CR32","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/0014-2999(94)00477-3","volume":"264","author":"J-C Liu","year":"1994","unstructured":"Liu J-C, Cox RF, Greif GJ, Freedman JE, Waszczak BL (1994) The putative dopamine D3 receptor agonist 7-OH-DPAT: lack of mesolimbic selectivity. Eur J Pharmacol 264:269\u2013278","journal-title":"Eur J Pharmacol"},{"key":"BF02246662_CR33","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/0091-3057(85)90071-1","volume":"23","author":"MR Lynch","year":"1985","unstructured":"Lynch MR, Wise RA (1985) Relative effectiveness of pimozide, haloperidol and trifluoperazine on self-stimulation rate-intensity functions. Pharmacol Biochem Behav 23:777\u2013780","journal-title":"Pharmacol Biochem Behav"},{"key":"BF02246662_CR34","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1002\/ddr.430300409","volume":"30","author":"J McElroy","year":"1993","unstructured":"McElroy J, Zeller, K, Amy K, Ward K, Cawley J, Mazzola A, Keim W, Rohrbach K (1993) In vivo agonist properties of 7-hydroxy-N, N-di-N-propyl-2-aminotetralin, a dopamine D3-selective receptor ligand. Drug Dev Res 30:257\u2013259","journal-title":"Drug Dev Res"},{"key":"BF02246662_CR35","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/0091-3057(94)90565-7","volume":"48","author":"J McElroy","year":"1994","unstructured":"McElroy J (1994) Discriminative stimulus properties of 7-OH-DPAT, a dopamine D3-selective receptor ligand. Pharmacol Biochem Behav 48:531\u2013533","journal-title":"Pharmacol Biochem Behav"},{"key":"BF02246662_CR36","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/0922-4106(94)90212-7","volume":"266","author":"RG MacKenzie","year":"1994","unstructured":"MacKenzie RG, VanLeeuwen D, Pugsley TA, Shih YH, Demattos S, Tang L, Todd RD, O'Malley KL (1994) Characterization of the human dopamine D3 receptor expressed in transfected cell lines. Eur J Pharmacol [Mol Pharmacol Sec] 266:79\u201385","journal-title":"Eur J Pharmacol [Mol Pharmacol Sec]"},{"key":"BF02246662_CR37","doi-asserted-by":"crossref","first-page":"R5","DOI":"10.1016\/0014-2999(94)90127-9","volume":"261","author":"PE Mallet","year":"1994","unstructured":"Mallet PE, Beninger RJ (1994) 7-OH-DPAT produces place conditioning in rats. Eur J Pharmacol 261:R5-R6","journal-title":"Eur J Pharmacol"},{"key":"BF02246662_CR38","doi-asserted-by":"crossref","first-page":"R5","DOI":"10.1016\/0014-2999(93)90674-7","volume":"249","author":"E Meller","year":"1993","unstructured":"Meller E, Bohmaker K, Goldstein M, Basham DA (1993) Evidence that striatal synthesis-inhibiting autoreceptors are dopamine D3 receptors. Eur J Pharmacol 249:R5-R6","journal-title":"Eur J Pharmacol"},{"key":"BF02246662_CR39","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1007\/BF00169305","volume":"336","author":"TB Mulder","year":"1987","unstructured":"Mulder TB, de Vries JB, Dijkstra D, Wiechers JW, Grol CJ, Horn AS (1987) Further in vitro and in vivo studies with the putative presynaptic dopamine agonistN, N-dipropyl-7-hydroxy-2-aminotetralin. Naunyn Schmiedeberg's Arch Pharmacol 336: 494\u2013501","journal-title":"Naunyn Schmiedeberg's Arch Pharmacol"},{"key":"BF02246662_CR40","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/0922-4106(92)90164-Q","volume":"227","author":"AM Murray","year":"1992","unstructured":"Murray AM, Ryoo H, Joyce JN (1992) Visualization of dopamine D3-like receptors in human brain with (125l)epidepride. Eur J Pharmacol 227:443\u2013445","journal-title":"Eur J Pharmacol"},{"key":"BF02246662_CR41","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/0091-3057(91)90209-K","volume":"39","author":"S Nakajima","year":"1991","unstructured":"Nakajima S, O'Regan NB (1991) The effects of dopaminergic agonists and antagonists on the frequency-response function for hypothalamic self-stimulation in the rat. Pharmacol Biochem Behav 39:465\u2013468","journal-title":"Pharmacol Biochem Behav"},{"key":"BF02246662_CR42","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1037\/0735-7044.107.1.161","volume":"107","author":"S Nakajima","year":"1993","unstructured":"Nakajima S, Liu X, Lau CL (1993) Synergistic interaction of D1 and D2 dopamine receptors in the modulation of the reinforcing effect of brain stimulation. Behav Neurosci 107:161\u2013165","journal-title":"Behav Neurosci"},{"key":"BF02246662_CR43","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/0014-2999(93)90963-I","volume":"234","author":"B Parsons","year":"1993","unstructured":"Parsons B, Stanley M, Javitch J (1993) Differential visualization of dopamine D2 and D3 receptors in rat brain. Eur J Pharmacol 234:269\u2013272","journal-title":"Eur J Pharmacol"},{"key":"BF02246662_CR44","volume-title":"The rat brain in stereotaxic coordinates","author":"G Paxinos","year":"1986","unstructured":"Paxinos G, Watson C (1986) The rat brain in stereotaxic coordinates. Academic Press, New York"},{"key":"BF02246662_CR45","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1007\/BF00427967","volume":"80","author":"M Poncelet","year":"1983","unstructured":"Poncelet M, Chermat R, Soubrie P, Simon P (1983) The progressive ratio schedule as a model for studying the psychomotor stimulant activity of drugs in the rat. Psychopharmacology 80:184\u2013189","journal-title":"Psychopharmacology"},{"key":"BF02246662_CR46","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/0028-3908(78)90007-2","volume":"17","author":"BJ Sahakian","year":"1978","unstructured":"Sahakian BJ, Koob GF (1978) The relationship between pipradrol-induced responding for electrical brain stimulation, stereotyped behaviour and locomotor activity. Neuropharmacology 17:363\u2013366","journal-title":"Neuropharmacology"},{"key":"BF02246662_CR47","doi-asserted-by":"crossref","first-page":"R1","DOI":"10.1016\/0014-2999(93)90259-K","volume":"242","author":"H Schoemaker","year":"1993","unstructured":"Schoemaker H (1993) [3H]7-OH-DPAT labels both dopamine D3 receptors and\u03c3 sites in the bovine caudate nucleus. Eur J Pharmacol 242:R1-R2","journal-title":"Eur J Pharmacol"},{"key":"BF02246662_CR48","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/0165-6147(94)90323-9","volume":"15","author":"P Seeman","year":"1994","unstructured":"Seeman P, Van Tol HHM (1994) Dopamine receptor pharmacology. Trends Pharmacol Sci 15:264\u2013270","journal-title":"Trends Pharmacol Sci"},{"key":"BF02246662_CR49","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1038\/347146a0","volume":"347","author":"P Sokoloff","year":"1990","unstructured":"Sokoloff P, Giros B, Martres MP, Bouthenet ML, Schwartz JC (1990) Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neuroleptics. Nature 347:146\u2013151","journal-title":"Nature"},{"key":"BF02246662_CR50","first-page":"224","volume":"42","author":"P Sokoloff","year":"1992","unstructured":"Sokoloff P, Giros B, Martres MP, Andrieux M, Besancon R, Pilon C, Bouthenet ML, Souil E, Schwartz JC (1992) Localization and function of the D3 dopamine receptor. Arzneimittelforschung 42:224\u2013230","journal-title":"Arzneimittelforschung"},{"key":"BF02246662_CR51","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/0091-3057(86)90026-2","volume":"25","author":"L Stahle","year":"1986","unstructured":"Stahle L, Ungerstedt U (1986) Effects of neuroleptic drugs on the inhibition of exploratory behaviour induced by a low dose of apomorphine: implications for the identity of dopamine receptors. Pharmacol Biochem Behav 25:473\u2013480","journal-title":"Pharmacol Biochem Behav"},{"key":"BF02246662_CR52","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/0091-3057(89)90426-7","volume":"33","author":"MS Starr","year":"1989","unstructured":"Starr MS, Starr BS (1989) Behavioural synergism between the dopamine agonists SKF 38393 and LY 171555 in dopamine-depleted mice: antagonism by sulpiride reveals only stimulant postsynaptic D-2 receptors. Pharmacol Biochem Behav 33: 41\u201344","journal-title":"Pharmacol Biochem Behav"},{"key":"BF02246662_CR53","first-page":"14","volume-title":"The neuropharmacological basis of reward","author":"JR Stellar","year":"1989","unstructured":"Stellar JR, Rice MB (1989) Pharmacological basis of intracranial self-stimulation reward. In: JM Liebman, SJ Cooper (eds) The neuropharmacological basis of reward. Oxford University Press, Oxford p 14\u201365"},{"key":"BF02246662_CR54","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/BF01283032","volume":"95","author":"K Svensson","year":"1994","unstructured":"Svensson K, Carlsson A, Waters N (1994a) Locomotor inhibition by the D3 ligandR-(+)-7-OH-DPAT is independent of changes in dopamine release. J Neural Transm [Gen Sect] 95:71\u201374","journal-title":"J Neural Transm [Gen Sect]"},{"key":"BF02246662_CR55","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/0014-2999(94)90718-8","volume":"263","author":"K Svensson","year":"1994","unstructured":"Svensson K, Carlsson A, Huff RM, Kling-Petersen T, Waters N (1994b) Behavioral and neurochemical data suggest functional differences between dopamine D2 and D3 receptors. Eur J Pharmacol 263:235\u2013243","journal-title":"Eur J Pharmacol"},{"key":"BF02246662_CR56","first-page":"475","volume":"270","author":"L Tang","year":"1994","unstructured":"Tang L, Todd RD, O'Malley KL (1994) Dopamine D2 and D3 receptors inhibit dopamine release. J Pharmacol Exp Ther 270:475\u2013479","journal-title":"J Pharmacol Exp Ther"},{"key":"BF02246662_CR57","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/0014-2999(91)90451-U","volume":"199","author":"W Timmerman","year":"1991","unstructured":"Timmerman W, Tepper PG, Dijkstra D, Stoelwinder H, Grol CJ, Westerink BHC, Horn AS (1991) Enantiomers of monohydroxy-2-aminotetralin derivatives and their activity at dopamine autoreceptors as studied by brain dialysis. Eur J Pharmacol 199:145\u2013151","journal-title":"Eur J Pharmacol"},{"key":"BF02246662_CR58","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0014-2999(84)90512-0","volume":"97","author":"PB Timmermans","year":"1984","unstructured":"Timmermans PB, Mathy MJ, Wilffert B, Kalkman HO, Smit G, Dijkstra D, Horn, AS, and Van Zwieten PA (1984) \u03b11\/\u03b12-adrenoceptor agonist selectivity of mono- and dihydroxy-2-N,N-di-n-propylaminotetralins. Eur J Pharmacol 97:55\u201365","journal-title":"Eur J Pharmacol"},{"key":"BF02246662_CR59","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/292463a0","volume":"292","author":"K Tsuruta","year":"1981","unstructured":"Tsuruta K, Frey EA, Grewe CW, Cote TE, Eskay RL, Kebabian JW (1981) Evidence that LY-141865 specifically stimulates the D-2 dopamine receptor. Nature 292:463\u2013465","journal-title":"Nature"},{"key":"BF02246662_CR60","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/0014-2999(93)90377-T","volume":"243","author":"M Buuse Van den","year":"1993","unstructured":"Van den Buuse M (1993) Effects of 7-hydroxy-N, N-di-n-propylaminotetralin on behaviour and blood pressure of spontaneously hypertensive rats. Eur J Pharmacol 243:169\u2013177","journal-title":"Eur J Pharmacol"}],"container-title":["Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02246662.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF02246662\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02246662","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,16]],"date-time":"2019-05-16T14:30:23Z","timestamp":1558017023000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF02246662"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1996,4]]},"references-count":60,"journal-issue":{"issue":"3","published-print":{"date-parts":[[1996,4]]}},"alternative-id":["BF02246662"],"URL":"https:\/\/doi.org\/10.1007\/bf02246662","relation":{},"ISSN":["0033-3158","1432-2072"],"issn-type":[{"value":"0033-3158","type":"print"},{"value":"1432-2072","type":"electronic"}],"subject":[],"published":{"date-parts":[[1996,4]]}}}